companydata.dkcompanydata.dk

AJ Vaccines A/S: Financial statements 2022

CVR: 37911143

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 420,982,000 and a net result of DKK -268,090,000 compared with DKK -486,388,000 the year before. That is an increase of 19.6% compared with the year before. The profit margin was -63.7%. Equity in the 2022 report amounted to DKK 994,663,000. The solvency ratio was 64.8%. The company had 556 employees in the financial year.

Revenue
DKK 420,982,000
Gross Profit
DKK -65,971,000
Profit/Loss
DKK -268,090,000
Equity
DKK 994,663,000
Total Assets
DKK 1,534,005,000
Employees
556

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022421M-66M-268.1M994.7M556
2021351.9M-304M-486.4M815.9M558
2020351.6M-313.9M-450.2M1.1B702
2019323.5M-224.5M-288.6M1.2B719
2018362.2M-150.7M-244.5M903.2M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on AJ Vaccines A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

AJ Vaccines A/S: The 2021 annual report is outJul 9, 2022

AJ Vaccines A/S has published its annual report for 2021. Revenue came to DKK 351,862,000, and the net result was DKK -486,388,000.

Shan-E-Abbas Ashary joins the board of AJ Vaccines A/SFeb 1, 2022

As of February 1, 2022, Shan-E-Abbas Ashary has joined the board of directors of AJ Vaccines A/S.

Abdulaziz Hamad Aljomaih joins the board of AJ Vaccines A/SFeb 1, 2022

As of February 1, 2022, Abdulaziz Hamad Aljomaih has joined the board of directors of AJ Vaccines A/S.

Ole Vahlgren joins AJ Vaccines A/S as adm. dir.Feb 1, 2022

As of February 1, 2022, Ole Vahlgren is registered as adm. dir. of AJ Vaccines A/S.

Jerome Christian Roger Cabannes steps down as director of AJ Vaccines A/SFeb 1, 2022

As of February 1, 2022, Jerome Christian Roger Cabannes has stepped down as director of AJ Vaccines A/S.

Tabassum Khan leaves the board of AJ Vaccines A/SJan 31, 2022

As of January 31, 2022, Tabassum Khan has left the board of directors of AJ Vaccines A/S.

Abdulaziz Hamad Aljomaih leaves the board of AJ Vaccines A/SJan 31, 2022

As of January 31, 2022, Abdulaziz Hamad Aljomaih has left the board of directors of AJ Vaccines A/S.

Jesper Helmuth Larsen steps down as adm. dir. of AJ Vaccines A/SJan 31, 2022

As of January 31, 2022, Jesper Helmuth Larsen has stepped down as adm. dir. of AJ Vaccines A/S.

About AJ Vaccines A/S

AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.

Source: annual report 2025, Danish Business Authority

Other financial years